by Stacey Johnson | Nov 4, 2022
Despite valiant efforts by countless people and organizations, misinformation and a lack of public trust in science continue to be prevalent themes in 2022. Day two of the Till & McCulloch Meetings in Vancouver kicked off with an informative plenary exploring...
by Kevin Robb | Oct 14, 2022
My heart is pounding, and my islets are secreting. Maybe it’s my fifth cup of sugary coffee kicking in, or maybe they’ve been inspired by the plenary session I’m recalling. While the former is more likely, I toy with the idea of the latter. In the “Clinical...
by Stacey Johnson | Sep 30, 2022
After returning from CellCAN’s 2022 Strategic Forum in Ottawa, Ontario, where Canada’s cell and gene therapy biomanufacturing community came together to share information and network, it is clear that the country’s biomanufacturing landscape is improving. As I and...
by Sara M. Nolte | Sep 21, 2022
We (or maybe it’s just me) talk about cancer immunotherapy around here A LOT. It’s hard not to when there are so many new advancements in this field of cancer research! I thought it was time to provide a guide to cancer immunotherapy, highlighting some of the more...
by Cal Strode | Sep 15, 2022
OmniaBio Inc., a subsidiary of CCRM, is building the largest facility of its kind in Canada, providing specialized manufacturing to the flourishing cell and gene therapy (CGT) industry. The new contract development and manufacturing organization (CDMO) will focus on...
by Cal Strode | Aug 17, 2022
Launched in June of 2015, ExCellThera is a clinical-stage biotechnology company making strides in developing robust and cost-effective processes for growing blood stem cells for therapeutic use, backed by award-winning proprietary technology. The company was founded...
Comments